BZP

A stimulant that was sold as "legal ecstasy" in the late 2000s, and was one of the first drugs widely marketed as a "research chemical." It has a much less favourable effect profile and has fallen out of popularity greatly since it was banned in many countries.

BZP molecular structure diagram from the DrugsPRO substance library.

Also known as: A2, Frenzy, Nemesis, N-benilglicin-piperazin, Party pills, 1-Benzilpiperazin

Classification

Chemical: Piperazine
Psychoactive: Stimulant
Tag: Habit-Forming
Tag: Research-Chemical

Effects

Stimulation
Physical Energy
Loss Of Appetite
Jaw Tension
Dry Mouth
Palpitations
Euphoria
Increased Focus
Empathy Enhancement
Anxiety
Contentment
Sociability Enhancement
Increased Music Appreciation
Auditory Enhancement
Blurred Vision
Brightness Enhancement
Contrast Enhancement
Distorted Touch

Routes of Administration

Oral

Dosage

Common: 70-100 mg
Heavy: 150+ mg
Light: 40-70 mg
Strong: 100-130 mg
Threshold: 25 mg

Duration

Onset: 0.5-1.5 h
Peak: 2-4 h
Offset: 4-8 h
After Effects: 8-24 h
Total Duration: 6-10 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

BZP